The Duke Comprehensive Stroke Center, certified by the Joint Commission, is among a select group of hospitals that meet the highest standard of stroke care in the United States. Originally named the Duke Center for Cerebrovascular Disease, the Center was founded by Albert Heyman, MD, in 1966 as a collaborative effort of the NIH and the Veterans Administration.
The Comprehensive Stroke Center is part of Duke University Hospital, which has received the American Heart Association’s (AHA) Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award for the past four years. This award, the highest that the AHA offers, recognizes commitment to providing the best possible care for stroke.
Based in the Department of Neurology, the Comprehensive Stroke Center has expanded to develop affiliated programs and includes faculty from an extensive list of clinical departments, research laboratories, and university centers within the School of Medicine and Duke Health System. These include affiliations with the:
- Duke Clinical Research Institute
- Duke Center for Genomic and Computational Biology
- Duke Multidisciplinary Neuroprotection Laboratories
Research activities range from laboratory studies based on molecular biological approaches to neuropharmacology, neurophysiology, developmental neurobiology, receptor biology, cell biology, and behavioral recovery. The affiliated Multidisciplinary Neuroprotection Laboratories focus on understanding the pathophysiology of stoke and acute brain injury and to developing novel treatments.
Duke Neurology Research Round Up, January 2023
The final month of 2022 saw the release of 12 new peer-reviewed journal articles written or co-written by members of the Duke Neurology Department. Highlights of our most recent publications include an evaluation of a training program designed to improve the delivery of epilepsy care in Uganda, a review of recent advances in the treatment of carpal tunnel syndrome, and a discussion of treatment options for the autoimmune condition known as neuromyelitis optica spectrum disorder (NMOSD).
Duke Neurology 2022: A Year in Review (Part 2 of 2)
The Duke Neurology Department continued to build on its success in the second half of 2022. The final six months of 2022 saw Duke University Hospital receive national rankings for neurology and neurosurgery, our first endowed professorship dedicated to help treat and understand amyotrophic lateral sclerosis (ALS), and recognition as the country’s second national center of excellence for dystonia among other achievements.
Duke Neurology 2022: A Year in Review (Part 1 of 2)
The Duke Neurology Department continued to grow and advance its missions of patient care, research, and training the next generation of neurology providers in 2022. Highlights from the first half of our calendar year include national and Duke-wide awards recognizing our faculty’s contributions to the field of diversity, inclusion, and neurology as a whole. The same period also saw the growth of the new Duke/UNC Alzheimer’s Disease Research Center and three of our neurologists don helmets and get in their racing care.
Duke Neurology Research Round Up, December 2022
Members of the Duke Neurology Department advanced the fields of clinical and translational neuroscience this November, contributing to 16 new peer-reviewed studies.
Fellow Spotlight: Ahmad Zamzam, MD
In the suburbs of Damascus, where Ahmad Zamzam, MD, grew up, a local expression translates to English roughly to “Stroke? Don’t even bother with treatment.” Disturbed at the lack of options reflected in this phrase, Zamzam decided he wanted to make a difference. Now, Zamzam is acting as a “pre-tending” member of our stroke service as one of our vascular neurology fellows.
Duke Neurology Research Round Up, November 2022
This October, members of the Duke Neurology Department advanced the fields of clinical and translational neuroscience, contributing to 14 new peer-reviewed studies and one book chapter. Highlights from our recent research include validation of new automated measures that evaluate handwriting for dystonia symptoms, a discussion of the effects of blood pressure on head and facial pain, and a discussion of presentations of a neuroimmune disorder known as MOGAD.
Duke Neurology Research Round Up, October 2022
Members of the Duke Neurology Department contributed to 12 new peer-reviewed journal articles published this September. Among other findings, this research answered important questions about the use of telehealth to manage chronic neurological conditions, investigated an alternative therapy’s potential benefit for fighting ALS, and synthesized the latest research findings about the role of the immune system and infection in the genesis of Alzheimer’s disease.
Duke Neurology Research Round Up, September 2022
Members of the Duke Neurology Department contributed to 12 new peer-reviewed journal articles published this August. Highlights include a review article examining evoked potentials used for deep brain stimulation in Parkinson’s, the healthcare received by veterans with epilepsy, the optimal stroke treatments for patients with cerebral venous thrombosis, and other topics.
APP Spotlight: Kristi Kehoe, PA-C
Kristi Kehoe, PA-C, had been interested in neurology since childhood, but didn’t settle into a specialty until after she completed her training and found a mentor in neurologist Howard Natter, MD. Kehoe was impressed by the complexity, dynamism, and eloquence of the field and has never looked back. In this week’s Spotlight interview, the new addition to our vascular neurology team talks to us about her work on Duke University Hospital’s inpatient stroke service.
Duke Neurology Research Round Up, August 2022
Members of the Duke Neurology Department contributed to eight articles and two correspondence letters published in peer-reviewed journals this July.